A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Clinical trial NCT07277660 · RECRUITING
Trial details
- NCT number
- NCT07277660
- Sponsor
- UCB Biopharma SRL
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-29
- Primary completion
- 2027-05-17
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.